國家衛生研究院 NHRI:Item 3990099045/12143
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12500/13673 (91%)
造访人次 : 2549206      在线人数 : 421
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/12143


    题名: Oxidized hyaluronic acid/adipic acid dihydrazide hydrogel as drug-carrier for cytoprotective medications-Preliminary results
    作者: Hsiao, MY;Lin, PC;Lin, AC;Wu, YW;Chen, WS;Lin, FH
    贡献者: Institute of Biomedical Engineering and Nanomedicine
    摘要: The oxidised hyaluronic acid/adipic acid dihydrazide hydrogel (oxi-HA/ADH) is a biocompatible and biodegradable hydrogel that has been applied in tissue engineering in musculoskeletal medicine. The present study investigated the feasibility of using oxi-HA/ADH as a drug carrier to incorporate cytoprotective medications for possible tendinopathy treatment. The cytocompatibility of oxi-HA/ADH, epigallocatechin gallate (EGCG) and piracetam were tested. Medications were incorporated in oxi-HA/ADH in the cross-linking process and the drug release profile was tested in vitro. Sprague-Dawley rats Achilles tendon-derived cells (TDCs) were isolated and cultured in a self-designed bioreactor exerting 8% cyclic strain at 0.5Hz for 8h. TDCs were treated with EGCG, piracetam, or no medication during mechanical loading. Gene expression of type I and type III collagen, Pparg, Sox9, and Runx2 (representing adipogenic, chondrogenic, and osteogenic lineages respectively) were analyzed by quantitative polymerase chain reaction. EGCG and piracetam showed no cytotoxicity at therapeutic range. The cumulative release profile of the drug-loaded oxi-HA/ADH showed a two-phase release of medication, a burst of 50-60% during the first 24h, followed by a steady release over 1-7 days. The decreased type I collagen expression and increased non-tenocyte lineage genes expression of TDCs upon 8% cyclic strain is reversed in the EGCG and piracetam treated groups, compared with non-treated group. Oxi-HA/ADH serves as a potential drug carrier that shows sustained-release characteristics. Anti-oxidative and cytoprotective medications, EGCG and piracetam, were able to suppress the aberrant non-tenocyte lineage genes expression of the TDCs upon excessive mechanical loading.
    日期: 2019-10
    關聯: Biomedical Engineering - Applications, Basis and Communications. 2019 Oct;31(5):Article number 1950036.
    Link to: http://dx.doi.org/10.4015/S1016237219500364
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85070622619
    显示于类别:[林峯輝] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    SCP85070622619.pdf769KbAdobe PDF377检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈